Elite Pharma Revenue, Profits - ELTP Quarterly Income Statement

Add to My Stocks
$0.09 $0 (0%) ELTP stock closing price Sep 19, 2018 (Closing)

ELTP stock valuation based on fundamental analysis involves checking and analyzing financial statements and not just the Elite Pharma stock price. The income statement is a summary of the revenue or sales, expenses and profitability - shown as Net Income, or lack of it. The income statement is generated for a specific period of time, typically a year or a quarter. The revenue increase to $2.17M for 2019 Q1 impacts the ELTP stock. Investors typically check year over year or quarter over quarter revenue growth. The operating expenses as shown in the Elite Pharma profit and loss statement for 2019 Q1 total to $1.33M. This line item shows that the operating expenses has decreased compared with last year. Also check: Elite Pharma assets and Elite Pharma free cash flow.

View and download details of revenue and profits for Elite Pharma for latest & last 40 quarters.
show more
Quarterly
Annual
View Previous Quarters
View Next Quarters
Fiscal year is Apr - Mar2019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q4
Elite Pharma Revenues or Net Sales
2.17M1.6M2.54M1.62M1.7M1.35M2.33M2.69M3.27M5.2M
Cost Of Goods Sold (COGS)1.58M-1.41M-1.01M-1.72M1.85M2.14M1.05M
Elite Pharma Gross Profit
-1.15M1.11M1M-1.18M--1.12M-0.5M
Research & Development Expense1.33M2.69M2.51M2.46M1.96M3.97M1.52M1.26M1.55M2.72M
Selling General & Admin Expense----------
Income Before Depreciation Depletion Amortization-1.65M-1.85M-2.05M-2.12M-2.23M-2.91M-1.7M-1.18M-1.21M-3.93M
Depreciation Depletion Amortization----------
Non Operating Income--0.1M-4.02M--1.81M3.44M5.5M2.4M1.06M
Interest Expense----------
Elite Pharma Pretax Income
-1.69M-2.82M-1.54M1.81M-2.16M-5.04M1.66M4.23M1.09M-3.11M
Provision for Income Taxes---1.05M---1.86M----0.52M
MinorityInterest----------
Investment Gains Losses----------
Other Income----------
Income Before Extraordinaries & Disc Operations-1.69M-2.83M-0.49M1.82M-2.17M-3.19M1.67M4.24M1.09M8.5M
Extraordinary Items & Discontinued Operations----------
Elite Pharma Profit/ Loss (Net Income)
-1.69M-2.83M-0.49M1.82M-2.17M-3.19M1.67M4.24M1.09M8.5M
Average Shares used to compute Diluted EPS803.05M796.64M795.12M788.79M819.32M838.67M910.51M816.03M722.78M902.1M
Average Shares used to compute Basic EPS803.05M795.9M788.44M782.43M819.32M838.67M904.76M806.87M722.78M662.18M
Income Before Nonrecurring Items-1.69M-2.83M-0.49M1.82M-2.17M-3.19M1.67M4.24M1.09M8.5M
Income from Nonrecurring Items----------
Elite Pharma Earnings Per Share Basic Net
0.000.000.000.000.000.030.000.030.000.04
Elite Pharma Earnings Per Share Diluted Net
0.000.000.000.000.00-0.010.000.000.000.04
EPS Diluted Before Nonrecurring Items0.000.000.000.000.00-0.010.000.000.000.04
Preferred Dividends Acc Pd----------
Dividends Common0.000.000.00-------
Dividend Per Share Common0.000.000.000.000.000.000.000.000.000.00
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

Before investing one should read a report on Elite Pharma stock analysis. It helps to look at the following income statement items:

  • Revenue: This is the inflow that is generated from the sale of goods or services and is $2.17M for this quarter of 2019 Q1. Our Elite Pharma revenue chart gives a clear visual representation of how the topline or sales growth has been. Investors often invest only in those companies where the revenue is growing at a steady rate.
  • Bottom line: The bottomline or the net income figure is arrived at by deducting all expenses from the topline which in this case is $-1.69M for ELTP stock. An improving bottomline implies that the company is growing its profits.

The income statement is also called the profit and loss statement. Apart from the ELTP income statement, one can check the Elite Pharma historical stock prices to check how the price has moved with time.

Elite Pharma Income Statement - Key Financial Ratios

PS Ratio (price sales ratio)
9.01
Dividend Yield
0%